Multiple Myeloma
The FDA has been in overdrive lately, fast-tracking approvals to encourage scientific development in the name of “innovation.” But the impact on patients isn’t always clear. Especially for people with cancer. The FDA’s recent approval of panobinostat, marketed as Farydak, to treat a rare form of blood cancer called multiple…
